AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Down 28.2% in March

AstraZeneca PLC (OTCMKTS:AZNCF) was the recipient of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 320,500 shares, a decrease of 28.2% from the February 28th total of 446,500 shares. Based on an average daily volume of 3,200 shares, the short-interest ratio is currently 100.2 days.

AstraZeneca Stock Performance

OTCMKTS:AZNCF opened at $147.47 on Friday. The firm’s 50-day moving average is $146.58 and its 200-day moving average is $142.79. AstraZeneca has a 52-week low of $120.64 and a 52-week high of $175.00.

AstraZeneca Increases Dividend

The company also recently declared a dividend, which was paid on Monday, March 24th. Shareholders of record on Friday, February 21st were issued a $2.10 dividend. This is a boost from AstraZeneca’s previous dividend of $1.00. The ex-dividend date was Wednesday, February 19th. AstraZeneca’s dividend payout ratio is 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.